Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study. (Q27851468)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.
scientific article

    Statements

    Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study. (English)
    1 reference
    0 references
    Valentina Nekljudova
    0 references
    0 references
    Andreas du Bois
    0 references
    Marcus Schmidt
    0 references
    Nicolai Maass
    0 references
    Tanja Cufer
    0 references
    Felix E de Jongh
    0 references
    Eduard Maartense
    0 references
    Christoph Zielinski
    0 references
    Manfred Kaufmann
    0 references
    Wolfgang Bauer
    0 references
    Klaus H Baumann
    0 references
    Michael R Clemens
    0 references
    Ralph Duerr
    0 references
    Christoph Uleer
    0 references
    Michael Andersson
    0 references
    20 April 2009
    0 references
    27
    0 references
    1999-2006
    0 references
    12
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit